Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip ; day:17 ; month:05 ; year:2023 ; extent:12
Advanced healthcare materials ; (17.05.2023) (gesamt 12)
- Urheber
-
Cui, Haijun
Sun, Xueyuan
Schilling, Marcel
Herold‐Mende, Christel
Reischl, Markus
Levkin, Pavel A.
Popova, Anna A.
Turcan, S̨evin
- DOI
-
10.1002/adhm.202300591
- URN
-
urn:nbn:de:101:1-2023051815054088419607
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cui, Haijun
- Sun, Xueyuan
- Schilling, Marcel
- Herold‐Mende, Christel
- Reischl, Markus
- Levkin, Pavel A.
- Popova, Anna A.
- Turcan, S̨evin
Ähnliche Objekte (12)
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
Repurposing FDA-approved drugs for anti-aging therapies
Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening
FDA
FDA
FDA
FDA
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
Repurposing FDA-approved drugs for anti-aging therapies
Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening
FDA
FDA
FDA
FDA
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
Repurposing FDA-approved drugs for anti-aging therapies
Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening
FDA
FDA
FDA